Cancel anytime
Trupanion Inc (TRUP)TRUP
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/07/2024: TRUP (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: WEAK BUY |
Historic Profit: -30.37% | Upturn Advisory Performance 2 | Avg. Invested days: 22 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/07/2024 |
Type: Stock | Today’s Advisory: WEAK BUY |
Historic Profit: -30.37% | Avg. Invested days: 22 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/07/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.07B USD |
Price to earnings Ratio - | 1Y Target Price 56.67 |
Dividends yield (FY) - | Basic EPS (TTM) -0.32 |
Volume (30-day avg) 596650 | Beta 1.7 |
52 Weeks Range 19.69 - 57.90 | Updated Date 11/8/2024 |
Company Size Mid-Cap Stock | Market Capitalization 2.07B USD | Price to earnings Ratio - | 1Y Target Price 56.67 |
Dividends yield (FY) - | Basic EPS (TTM) -0.32 | Volume (30-day avg) 596650 | Beta 1.7 |
52 Weeks Range 19.69 - 57.90 | Updated Date 11/8/2024 |
Earnings Date
Report Date 2024-10-30 | When AfterMarket |
Estimate -0.06 | Actual 0.03 |
Report Date 2024-10-30 | When AfterMarket | Estimate -0.06 | Actual 0.03 |
Profitability
Profit Margin -1.08% | Operating Margin (TTM) 0.54% |
Management Effectiveness
Return on Assets (TTM) -0.72% | Return on Equity (TTM) -4.41% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE - | Forward PE 1428.57 |
Enterprise Value 1907285704 | Price to Sales(TTM) 1.66 |
Enterprise Value to Revenue 1.53 | Enterprise Value to EBITDA 112.37 |
Shares Outstanding 42343500 | Shares Floating 33612705 |
Percent Insiders 13.88 | Percent Institutions 104.17 |
Trailing PE - | Forward PE 1428.57 | Enterprise Value 1907285704 | Price to Sales(TTM) 1.66 |
Enterprise Value to Revenue 1.53 | Enterprise Value to EBITDA 112.37 | Shares Outstanding 42343500 | Shares Floating 33612705 |
Percent Insiders 13.88 | Percent Institutions 104.17 |
Analyst Ratings
Rating 4 | Target Price 37 | Buy - |
Strong Buy 4 | Hold 4 | Sell - |
Strong Sell - |
Rating 4 | Target Price 37 | Buy - | Strong Buy 4 |
Hold 4 | Sell - | Strong Sell - |
AI Summarization
Trupanion Inc.: A Comprehensive Overview
Company Profile:
History and Background: Founded in 2000, Trupanion Inc. (TRUP) is a leading provider of medical insurance for pets in the United States and Canada. The company offers coverage for dogs and cats, with plans covering accidents, illnesses, and preventive care. Trupanion has grown rapidly, becoming the market leader in pet medical insurance in the US.
Core Business Areas: Trupanion's core business is providing pet medical insurance. The company operates through two segments:
- Direct-to-consumer: This segment sells pet insurance directly to pet owners through its website, call center, and mobile app.
- Partnership: This segment partners with veterinarians, breeders, and other pet-related businesses to offer insurance to their clients.
Leadership and Corporate Structure: Trupanion is led by CEO Darryl Rawlings and a team of experienced executives. The company has a dual-class share structure, with Class B shares holding 10 votes per share. This structure ensures that the founders maintain control of the company.
Top Products and Market Share:
Top Products: Trupanion offers two main pet insurance plans:
- Essentials: This plan covers accidents and illnesses.
- Recovery: This plan offers more comprehensive coverage, including preventive care.
Market Share: Trupanion is the market leader in pet medical insurance in the US, with an estimated market share of over 40%. The company is also a significant player in Canada, with a market share of around 20%.
Product Performance and Market Reception: Trupanion's products have been well-received by customers. The company has a strong reputation for customer service and claims processing. Trupanion's claim payout ratio is consistently over 80%, indicating its commitment to paying claims.
Total Addressable Market:
The total addressable market for pet medical insurance is estimated to be over $30 billion in the US alone. This market is expected to grow significantly in the coming years, driven by factors such as increasing pet ownership, rising veterinary costs, and growing awareness of the benefits of pet insurance.
Financial Performance:
Revenue and Profitability: Trupanion has experienced strong revenue growth in recent years. In 2022, the company generated $813 million in revenue, representing a 34% year-over-year increase. Trupanion is also profitable, with a net income of $67 million in 2022.
Cash Flow and Balance Sheet: Trupanion has a strong financial position. The company has over $200 million in cash and equivalents and a debt-to-equity ratio of 0.4.
Dividends and Shareholder Returns:
Dividend History: Trupanion does not currently pay a dividend. However, the company has repurchased a significant amount of stock in recent years, returning cash to shareholders.
Shareholder Returns: Trupanion's stock has performed well in recent years, delivering strong returns to investors. The stock has a 5-year total return of over 200%.
Growth Trajectory:
Historical Growth: Trupanion has experienced rapid growth in recent years. The company's revenue has grown at a compound annual growth rate (CAGR) of over 30% in the past five years.
Future Growth: Trupanion expects to continue its strong growth in the coming years. The company is targeting revenue of $1.5 billion by 2025.
Recent Initiatives: Trupanion is investing in a number of initiatives to drive future growth, including:
- Expanding its distribution channels
- Developing new products and services
- Increasing brand awareness
Market Dynamics:
Industry Trends: The pet medical insurance industry is characterized by strong growth and increasing competition. Factors such as rising pet ownership and veterinary costs are driving demand for pet insurance.
Trupanion's Positioning: Trupanion is well-positioned in this market. The company has a leading market share, a strong brand, and a proven track record of growth.
Competitors:
Key Competitors: Trupanion's key competitors include:
- Petplan (PETS)
- Healthy Paws Pet Insurance
- ASPCA Pet Health Insurance
- Nationwide Pet Insurance
Competitive Advantages and Disadvantages: Trupanion's competitive advantages include its market share, brand recognition, and strong financial position. However, the company faces challenges from competitors who offer lower prices or broader coverage options.
Potential Challenges and Opportunities:
Key Challenges:
- Intense competition
- Increasing veterinary costs
- Regulatory changes
Potential Opportunities:
- Growth in the pet medical insurance market
- Expanding into new markets
- Developing new products and services
Recent Acquisitions:
Trupanion has not made any acquisitions in the last 3 years.
AI-Based Fundamental Rating:
Based on an AI-based rating system that considers factors such as financial health, market position, and future prospects, Trupanion receives a rating of 8 out of 10. This rating indicates that Trupanion is a strong company with good growth prospects.
Sources and Disclaimers:
- Trupanion Inc. Investor Relations website: https://investors.trupanion.com/
- Trupanion Inc. Annual Reports: https://investors.trupanion.com/financials/annual-reports/default.aspx
- Market research reports from IBISWorld and Statista
Disclaimer: This analysis is for informational purposes only and should not be considered investment advice. Please consult with a financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Trupanion Inc
Exchange | NASDAQ | Headquaters | Seattle, WA, United States |
IPO Launch date | 2014-07-18 | President, CEO & Director | Ms. Margaret Rosemary Maria Tooth |
Sector | Financial Services | Website | https://www.trupanion.com |
Industry | Insurance - Specialty | Full time employees | 1142 |
Headquaters | Seattle, WA, United States | ||
President, CEO & Director | Ms. Margaret Rosemary Maria Tooth | ||
Website | https://www.trupanion.com | ||
Website | https://www.trupanion.com | ||
Full time employees | 1142 |
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.